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 Abstract
A twenty-six year old secundagravida booked her pregnancy 
at 14 weeks gestation. It was noted in the past obstetric history 
that the woman had lost her first child at 41 weeks gestation, 
delivering a stillborn baby weighing 4.2kg. At 34 weeks into 
the second pregnancy mild polyhydramnios was noted and 
the patient was admitted. During her hospitalisation the 
patient complained of having passed a small renal stone. Two 
serum calcium levels were found to be significantly elevated 
3.36mmol/l and 3.2mmol/l. Serum parathormone was found 
to be significantly elevated - 247pg/ml (Normal levels: 12.0 
- 72.0pg/ml) and an ultrasound scan of the neck confirmed 
the presence of a parathyroid adenoma. A parathyroidectomy 
was performed and the postoperative period was uneventful. 
The rest of the pregnancy was uneventful and at 38 weeks 
gestation a healthy child was delivered vaginally. In view of 
this woman’s past history and the events occurring during the 
second pregnancy it may be useful to consider obtaining serum 
levels of calcium in cases of idiopathic stillbirth.
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Case report 
Mrs E. I. was a 26 year old foreign Caucasian woman 
who booked her second pregnancy at 14 weeks gestation. She 
gave an obstetric history indicating that she had sustained a 
stillborn child weighing 4.2 kg at 41 weeks gestation. In view of 
the adverse obstetric history, antenatal care was carried out at 
Mater Dei Hospital. The patient’s body mass index during her 
booking visit in the first trimester was 23.3kg/m2. Due to the 
past history of stillbirth and its elevated birthweight, an oral 
glucose tolerance was carried out at 28 weeks gestation and 
was found to be normal  (American Diabetic Association ) – 
fasting: 4.49mmol/l, 1st hour: 4.78mmol/l,  2nd hour: 3.95mmol/l 
and 3rd hour: 4.15mmol/l. In the previous pregnancy there 
was no history of a metabolic problem in particular impaired 
carbohydrate metabolism. 
The pregnancy progressed uneventfully until 34 weeks 
gestation when mild polyhydramnios was noted clinically and 
this was confirmed ultrasonically (Amniotic Fluid Index:  23.5 
cm - 90th centile). In view of this finding and the past obstetric 
history the patient was hospitalised for closer maternal-fetal 
surveillance. Growth ultrasound scans and Doppler flow studies 
were within normal limits. Blood glucose levels remained within 
the normal range. On the third day of hospitalisation the patient 
complained of having passed a small renal stone. There was no 
history of nephrolithiasis from either the patient’s past history 
or family history. 
Following the passage of the urinary calculus, two serum 
calcium levels were taken and found to be significantly elevated 
at 3.36mmol/l and 3.2mmol/l (normal range: 2.15 - 2.55mmol/l). 
In view of the hypercalcaemia, serum parathormone level was 
investigated and was also found to be significantly elevated : 
247pg/ml (normal range: 12.0 - 72.0pg/ml). An ultrasound of 
the anterior aspect of the neck was performed and confirmed 
the presence of a  2.4cm x 1.1 cm left inferior lateral parathyroid 
adenoma. The thyroid gland was normal and no cervical 
lymphadenopathy was noted. 
While the patient was still hospitalised an episode of elevated 
blood pressure (140/90mmHg) and two ++ proteinuria were 
noted on urinalysis. Renal function tests were within normal 
levels: urea 3.3mmol/l, creatinine 49µmol/l and the uric acid 
342µmol/l. Ultrasonic investigation of both kidneys showed 
hydronephrosis of the right kidney while the left kidney was 
normal. No renal calculi were detected ultrasonically.  
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Steroids in the form of 12mg dexamethasone were 
administered to reduce the risk of foetal respiratory distress 
syndrome if premature delivery was necessitated. The steroid 
administration may have been also useful in attenuating the 
adverse effects hypercalcaemia may have on the pregnancy. The 
patient remained normotensive and the proteinuria resolved 
without resorting to anti-hypertensive treatment.
A dual consultation was sought from the departments of 
surgery and endocrinology, and it was recommended that the 
patient undergo neck exploration. A parathyroidectomy was 
performed removing a 2.5cm left parathyroid gland which was 
histologically confirmed to be a parathyroid adenoma. The 
postoperative period was uneventful with close monitoring of 
serum calcium levels. Postoperatively normal serum calcium 
levels (serum calcium 2.24mmol/l) ensued throughout the 
pregnancy. The rest of the pregnancy was uneventful until 38+4 
weeks gestation when a unprovoked fetal heart deceleration was 
noted on cardiotocography. A decision was taken to induce the 
pregnancy and a healthy 3.08kg female child being delivered 
vaginally. Normocalcaemia for both mother and baby were 
confirmed in the postpartum period. The patient is being 
followed up by the Department of Endocrinology.
Discussion
In the general population the prevalence of primary 
hyperparathyroidism is 1.5 per 1000.1  This condition is more 
commonly found in women and 25% of cases are diagnosed 
in women during the childbearing years.1 The first case of 
parathyroid adenoma in pregnancy was recorded by Hunter in 
1930 and the literature is relatively scanty with only about 109 
cases reported in the medical literature.2 
The condition can lead to increased risk of maternal and 
perinatal mortality if left undiagnosed.2 The incidence of 
clinically significant complications resulting from delayed 
diagnosis or postponed surgery ranges from 17.6% to 23.5% in 
fetuses, including foetal or neonatal death, and 18.8% to 25.0% 
in mothers.3 
Maternal complications may start early in pregnancy 
with intractable hyperemesis gravidarum4 and miscarriage.5 
Maternal arrhythmias revealed clinically by palpitations 
and dyspnoea may result from hypercalcaemia-induced 
ventricular premature contraction bigeminy and trigeminy.6 
Antepartum haemorrhage7 and preterm labour8 may also occur 
in pregnancies complicated by primary hyperparathyroidism. 
In the postpartum period the loss of the protective effect 
provided by the placental calcium transport mechanism may 
lead to significant maternal risk for the development of acute 
hypercalcaemia and possible crisis immediately after delivery.9
Pre-eclampsia including the HELLP syndrome has been 
shown to commonly complicate primary hyperparathyroidism 
in pregnancy.10 Hultin et al have shown that parathyroid 
adenoma prior to delivery is significantly (p < 0.001) associated 
with pre-eclampsia, resulting an adjusted odds ratio of 6.89 
(95% confidence interval, 2.30 - 20.58).11 Our case had a blood 
pressure reading of 140/90mmHg and two pluses of proteinuria. 
After dexamethasone and following the parathyroidectomy the 
patient remained normotensive. It must be mentioned that 
this episode of high blood pressure may have been spurious 
reflecting the patient’s understandably anxious state of mind. 
The proteinuria may have resulted from the nephrolithiasis and 
hydronephrosis. 
The reason for the patient’s hospitalisation was due to 
the clinical detection of mild polyhydramnios which was 
confirmed ultrasonically. Similar to adults, hypercalcaemia 
may induce polyuria also in the fetus and this may explain the 
polyhydramnios.12 Progressive polyhydramnios itself may go on 
to cause preterm labour. The polyhydramnios did not worsen 
post-operatively, during the remaining four weeks of pregnancy. 
The presence of polyhydramnios and the passage of a urinary 
calculus raised the possibility of hyperparathyroidism. Such 
an event in pregnancy is exceptional but should be thoroughly 
investigated with serum calcium levels.13  
During pregnancy the calcium requirements of the fetus 
amount to approximately 30 g of calcium to mineralise its 
skeleton and maintain normal physiological processes.14  About 
80% of the calcium sequestered in the fetal skeleton at the end 
of gestation crosses the placenta during the third trimester and 
is mostly derived from intestinal dietary absorption of calcium 
during pregnancy.14 Pregnancy-related falls in total serum 
calcium are due to the reduction in the serum albumin, and, 
thereby, the albumin-bound fraction of the total calcium and 
the physiological haemodilution induced by pregnancy.15  The 
increased calcium requirements during pregnancy are attained 
by the doubling of intestinal calcium absorption.14
Recurrent miscarriage is known to occur in women with 
primary hyperparathyroidism and is associated with a 3.5-fold 
increase in miscarriage rates. Pregnancy loss often occurs in the 
late first trimester and second trimester.16 Pregnancy loss is more 
common as calcium levels exceed 2.85mmol/l, but can be seen 
at all elevated calcium levels.16 Intra-uterine growth retardation 
may occur in pregnancies with primary hyperparathyroidism. 
This may occur even after surgical treatment whereby severe 
placental calcification ensued and a severely intra-uterine 
growth restricted baby was born.17
Untreated cases of primary hyperparathyroidism during 
the neonatal period have included neonatal death, neonatal 
tetany and hyper/hypocalcaemia.18 Neonatal hypocalcaemia 
probably results from transient hypoparathyroidism consequent 
to abnormal suppression by fetal hypercalcaemia.
Medical treatment in pregnancy may be instituted in 
cases where surgery may be considered hazardous19 but the 
mainstay of treatment is surgical excision of the parathyroid 
adenoma.3,7,16,18 The first surgically treated case was reported 
in 1975 by Dorey and Gell, emphasising the diminished risk 
to both mother and fetus following parathyroidectomy.20 
Histological examination of a series by Schnatz et al3  revealed 
that  parathyroid adenomas were detected in 81.2% of cases, 
hyperplasia in 6.3%, and carcinoma in 12.5%. The postoperative 
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incidence of clinically significant complications from surgery 
was as low as 5.9% in fetuses and 0% in mothers. Postoperative 
hypocalcemia was detected in 62.5% of mothers and 17.6% of 
their newborns. All cases were easily managed with calcium 
replacement.3 In our case, postoperative serum calcium levels 
remained within normal limits in both mother and neonate.
This paper confirms that parathyroidectomy performed in 
the third trimester of pregnancy is effective. Postponing surgery 
may risk an adverse maternal and fetal outcome. Moreover 
considering this woman’s obstetric history and the literature 
review, estimation of serum calcium may prove useful in cases 
of idiopathic stillbirth and recurrent miscarriage.  
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